A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Jasmine Zain, David Claxton, Joseph Tuscano, Edward M. Newman, David R Gandara, Primo N Lara

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2016

Keywords

  • Clinical trials
  • Myelodysplastic syndrome
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Hematology

Cite this